Japanese Takeda to acquire Shire for $62bn

Japanese pharmaceutical company Takeda has agreed to acquire biotech company Shire for $62 billion.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

AbbVie to acquire Allergan for $63bn

25 June 2019 US drug maker AbbVie has agreed to buy Allergan, the Ireland-headquartered maker of Botox, for $63 billion, in the latest blockbuster deal for the pharmaceutical industry.

Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

31 October 2018 Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Americas

Takeda v Zydus: FTC intervenes in sham lawsuit claims

11 June 2018 The US Federal Trade Commission has filed an amicus brief urging a district court to reject Takeda’s claim that its patent infringement lawsuit brought under the Hatch-Waxman Act cannot be a sham.

More on this story

Americas

AbbVie to acquire Allergan for $63bn

25 June 2019 US drug maker AbbVie has agreed to buy Allergan, the Ireland-headquartered maker of Botox, for $63 billion, in the latest blockbuster deal for the pharmaceutical industry.

Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

31 October 2018 Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Americas

Takeda v Zydus: FTC intervenes in sham lawsuit claims

More on this story

Americas

AbbVie to acquire Allergan for $63bn

25 June 2019 US drug maker AbbVie has agreed to buy Allergan, the Ireland-headquartered maker of Botox, for $63 billion, in the latest blockbuster deal for the pharmaceutical industry.

Big Pharma

Takeda ‘to sell OTC business in Europe’ to fund Shire acquisition

31 October 2018 Japan-based Takeda Pharmaceuticals is reportedly planning to sell its European over-the-counter business to lessen its debt from acquiring biotech company Shire.

Americas

Takeda v Zydus: FTC intervenes in sham lawsuit claims